AGGRASTAT Iisrael - inglise - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Tigrastat 250 mcg/mL (12.5 mg/50 mL) Concentrate For Solution For I.V. Infusion Filipiinid - inglise - FDA (Food And Drug Administration)

tigrastat 250 mcg/ml (12.5 mg/50 ml) concentrate for solution for i.v. infusion

pharmada ilac san. ve tic. a.s.; importer: ambica international corporation; distributor: ambica international corporation - tirofiban (as hydrochloride monohydrate) - concentrate for solution for i.v. infusion - 250 mcg/ml (12.5 mg/50 ml)

Aggrastat 250 mcg/mL Concentrate Solution for IV Infusion Filipiinid - inglise - FDA (Food And Drug Administration)

aggrastat 250 mcg/ml concentrate solution for iv infusion

n/a; importer: aspen philippines inc.; distributor: aspen philippines inc. - tirofiban (as hydrochloride monohydrate) - concentrate solution for iv infusion - 250 mcg/ml

Atirroxan 12.5 mg 150 mL (250 mcg/mL) Concentrated Solution   for I.V. Infusion Filipiinid - inglise - FDA (Food And Drug Administration)

atirroxan 12.5 mg 150 ml (250 mcg/ml) concentrated solution for i.v. infusion

ambica international corporation; distributor: ambica international corporation - tirofiban (as hydrochloride monohydrate) - concentrated solution for i.v. infusion - 12.5 mg 150 ml (250 mcg/ml)